𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer

✍ Scribed by Wan-Li Cheng; Chia-Siu Wang; Ya-Hui Huang; Ying Liang; Paul Y. Lin; Chuen Hsueh; Yi-Chin Wu; Wei-Jan Chen; Chia-Jung Yu; Sheue-Rong Lin; Kwang-Huei Lin

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
433 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Complementary DNA microarrays have identified aberrantly expressed genes in patients with gastric cancer. One that encodes secretory leukocyte protease inhibitor (SLPI) is among the aberrantly expressed genes and is associated with metastasis in gastric cancers. We evaluated the potential of SLPI expression as a helpful biomarker for detection of gastric cancer. Tumor tissue and matching noncancerous mucosa were obtained from 60 patients immediately after gastric resection. SLPI expression levels were determined by Northern and Western blot tests and quantitative‐reverse transcriptase‐polymerase chain reaction (Q‐RT‐PCR). Paraffin‐fixed tumor tissues were used for immunohistochemistry study in 119 patients. A consistent result was obtained between all examinations except plasma SLPI. SLPI mRNA transcripts and protein were overexpressed in gastric cancer cells, and the depth of wall invasion was significantly greater in serosa‐invading (T3 and T4) cancers compared to the serosa‐free (T1 and T2) cancers. These enhanced expressions were significantly associated with lymph node metastasis, and were significantly higher in stages III and IV, and higher than those in stages I and II. Five‐year survival of patients with lower expression of the SLPI gene was significantly better than among patients with a higher expression. To better understand the function of SLPI in human gastric cancer cells, isogenic SLPI overexpressing cell lines (AZ521) were prepared. The migratory and invasive abilities were increased 4.4‐fold to 6.9‐fold, or 3.0‐fold to 4.1‐fold, respectively, in SLPI‐overexpressing cell lines. The results point to SLPI as a potential prognostic marker for gastric cancer and its function in cell invasion. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Therapeutic efficacy of once-daily oral
Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer
✍ Hiroshi Kobayashi; Tatsuo Yagyu; Kiyokazu Inagaki; Toshiharu Kondo; Mika Suzuki; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

## Abstract ## BACKGROUND Bikunin, a Kunitz‐type protease inhibitor, specifically inhibits tumor invasion and metastasis. ## METHODS The authors initially evaluated the therapeutic efficacy of once‐daily oral administration of different doses of bikunin against human ovarian carcinoma HRA cells

Optimization of a metastasizing human ga
Optimization of a metastasizing human gastric cancer model in nude mice
✍ Bertram Illert; Christoph Otto; Stephanie Braendlein; Arnulf Thiede; Wolfgang Ti 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

## Abstract Our purpose was to optimize the surgical orthotopic implantation (SOI) technique to create a reproducible gastric cancer model in nude mice with stable tumor growth and metastasizing course. We performed xenotransplantation of primary human tumor specimens from patients with gastric can

Inhibition of metastasis in human gastri
Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice
✍ Michio Watanabe; Yutaka Takahashi; Takahito Ohta; Masayashi Mai; Takuma Sasaki; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

BACKGROUND. Tissue inhibitors of nietalloproteinases (TIMPs) act as negative regulators of matrix metalloproteinases (MMPs) that degrade extracellular matrix. We evaluated the metastatic ability of the highly metastatic human gastric cell line KKLS, and that of cells transfected with exogenous TIMP-

Pharmacokinetic characterization of a hu
Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats
✍ Nobuhito Shibata; Michiharu Kageyama; Tomoyuki Kishida; Keisuke Kimura; Yukako Y 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract Throughout therapeutic drug monitoring of human immunodeficiency virus (HIV) protease inhibitors in HIV‐infected patients, it was found that plasma concentrations of saquinavir (SQV) were reduced in patients who had a habit of alcohol intake during double protease therapy with SQV and r

Enhanced efficiency of thermally targete
Enhanced efficiency of thermally targeted taxanes delivery in a human xenograft model of gastric cancer
✍ Baorui Liu; Mi Yang; Xiaolin Li; Xiaoping Qian; Zetian Shen; Yitao Ding; Lixia Y 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

Since successful chemotherapy with taxanes requires an improvement in their therapeutic index, especially by the reduction in unwanted systemic toxicity of either drug or adjuvants, we have investigated and are reporting results from an investigation of the use of a novel polymeric thermosensitive m

In vitro Metabolism of a Potent HIV-prot
In vitro Metabolism of a Potent HIV-protease Inhibitor (141W94) Using Rat, Monkey and Human Liver S9
✍ Rominder Singh; Sai Y. Chang; Lester C. E. Taylor 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

Compound 141W94 (Vertex VX478) (3S)-tetrahydro-3-furyl N-[((S,2Zt)-3-(4-amino-N-isobutylbenzenesulfonamido)-l-benzyl-2-hydroxypropyl] carbamate, is a potent HIV-protease inhibitor and is currently undergoing clinical trials. The purpose of this study was the rapid identification of the phase I and I